117 related articles for article (PubMed ID: 8287377)
21. Imbalanced follicle-stimulating hormone beta-subunit hormone biosynthesis in human pituitary adenomas.
Katznelson L; Alexander JM; Bikkal HA; Jameson JL; Hsu DW; Klibanski A
J Clin Endocrinol Metab; 1992 Jun; 74(6):1343-51. PubMed ID: 1375599
[TBL] [Abstract][Full Text] [Related]
22. [P21 expression of ras oncogene product in benign and malignant female mammary lesions].
Zhang JZ; Fan SC; Liu HF
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):302-3. PubMed ID: 7874767
[TBL] [Abstract][Full Text] [Related]
23. TPS cytosolic levels in non-malignant breast diseases.
Alvarez A; Martinez Rodriguez PI; Nuñez MI; Alba A; Allende MT; Ruibal Morell A
Int J Biol Markers; 1995; 10(3):183-5. PubMed ID: 8551064
[No Abstract] [Full Text] [Related]
24. Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone.
Zheng W; Lu JJ; Luo F; Zheng Y; Feng Yj; Felix JC; Lauchlan SC; Pike MC
Gynecol Oncol; 2000 Jan; 76(1):80-8. PubMed ID: 10620446
[TBL] [Abstract][Full Text] [Related]
25. Expression of platelet-derived growth factor B-chain and the platelet-derived growth factor receptor beta subunit in human breast tissue and breast carcinoma.
Coltrera MD; Wang J; Porter PL; Gown AM
Cancer Res; 1995 Jun; 55(12):2703-8. PubMed ID: 7780988
[TBL] [Abstract][Full Text] [Related]
26. p27/kip1 expression in normal epithelium, benign and neoplastic breast lesions.
De Paola F; Vecci AM; Granato AM; Liverani M; Monti F; Innoceta AM; Gianni L; Saragoni L; Ricci M; Falcini F; Amadori D; Volpi A
J Pathol; 2002 Jan; 196(1):26-31. PubMed ID: 11748638
[TBL] [Abstract][Full Text] [Related]
27. An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha 2 glycoprotein.
Bundred NJ; Miller WR; Walker RA
Histopathology; 1987 Jun; 11(6):603-10. PubMed ID: 3305282
[TBL] [Abstract][Full Text] [Related]
28. Tissue binding of lectins in disorders of the breast.
Franklin WA
Cancer; 1983 Jan; 51(2):295-300. PubMed ID: 6295598
[TBL] [Abstract][Full Text] [Related]
29. Inappropriate luteinizing hormone concentration in human breast cancer.
Gunasegaram R; Peh KL; Loganath A; Ang LC; Thiagaraj D; Kottegoda SR; Ratnam SS
Aust N Z J Surg; 1985 Apr; 55(2):127-31. PubMed ID: 2994618
[TBL] [Abstract][Full Text] [Related]
30. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte growth factor/scatter factor expression in human mammary epithelium.
Wang Y; Selden AC; Morgan N; Stamp GW; Hodgson HJ
Am J Pathol; 1994 Apr; 144(4):675-82. PubMed ID: 8160769
[TBL] [Abstract][Full Text] [Related]
32. An immunohistochemical study of the incidence and significance of human gonadotrophin and prolactin binding sites in normal and neoplastic human ovarian tissue.
Al-Timimi A; Buckley CH; Fox H
Br J Cancer; 1986 Mar; 53(3):321-9. PubMed ID: 3083857
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-releasing hormone regulates follicle-stimulating hormone beta-subunit gene expression in the male rat.
Rodin DA; Lalloz MR; Clayton RN
Endocrinology; 1989 Sep; 125(3):1282-9. PubMed ID: 2503366
[TBL] [Abstract][Full Text] [Related]
34. Serum hormones in human breast cancer subjects.
Krishnamoorthy G; Govindarajulu P; Ramalingam V
Neoplasma; 1989; 36(2):221-31. PubMed ID: 2497392
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical expression of the c-kit proto-oncogene product in human malignant and non-malignant breast tissues.
Chui X; Egami H; Yamashita J; Kurizaki T; Ohmachi H; Yamamoto S; Ogawa M
Br J Cancer; 1996 May; 73(10):1233-6. PubMed ID: 8630284
[TBL] [Abstract][Full Text] [Related]
36. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers.
Jankun J; Merrick HW; Goldblatt PJ
J Cell Biochem; 1993 Oct; 53(2):135-44. PubMed ID: 8227186
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of de novo synthesis of FSH by the Sertoli cell factor (SCF).
Chowdhury M; Steinberger A; Steinberger E
Endocrinology; 1978 Aug; 103(2):644-7. PubMed ID: 369842
[TBL] [Abstract][Full Text] [Related]
38. p53 mutations in benign breast tissue.
Millikan R; Hulka B; Thor A; Zhang Y; Edgerton S; Zhang X; Pei H; He M; Wold L; Melton LJ
J Clin Oncol; 1995 Sep; 13(9):2293-300. PubMed ID: 7666086
[TBL] [Abstract][Full Text] [Related]
39. Cells that express luteinizing hormone (LH) and follicle-stimulating hormone (FSH) beta-subunit messenger ribonucleic acids during the estrous cycle: the major contributors contain LH beta, FSH beta, and/or growth hormone.
Childs GV; Unabia G; Rougeau D
Endocrinology; 1994 Feb; 134(2):990-7. PubMed ID: 8299592
[TBL] [Abstract][Full Text] [Related]
40. Effects of castration on luteinizing hormone and follicle-stimulating hormone secretion by pituitary cells from male rats.
Kitahara S; Winters SJ; Attardi B; Oshima H; Troen P
Endocrinology; 1990 May; 126(5):2642-9. PubMed ID: 1691703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
